Pharmacokinetics and Tolerability of Rufinamide in Healthy Chinese Subjects
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine the pharmacokinetic (PK) and safety profile of
single and multiple doses of rufinamide. The effects of food and sex on the PK properties of
rufinamide in these Chinese volunteers were also evaluated.